Dermapharm Holding SE (ETR:DMP)

Germany flag Germany · Delayed Price · Currency is EUR
46.20
+0.55 (1.20%)
Apr 17, 2026, 5:35 PM CET
Market Cap2.49B +26.6%
Revenue (ttm)1.18B -1.4%
Net Income132.41M +16.4%
EPS2.46 +16.4%
Shares Out53.84M
PE Ratio18.79
Forward PE18.52
Dividend0.88 (1.90%)
Ex-Dividend DateJun 29, 2026
Volume13,255
Average Volume35,293
Open45.90
Previous Close45.65
Day's Range45.40 - 46.40
52-Week Range31.70 - 47.25
Beta0.87
RSI62.06
Earnings DateMay 13, 2026

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company a... [Read more]

Sector Healthcare
Founded 1991
Employees 3,551
Stock Exchange Deutsche Börse Xetra
Ticker Symbol DMP
Full Company Profile

Financial Performance

In 2025, Dermapharm Holding SE's revenue was 1.18 billion, a decrease of -1.43% compared to the previous year's 1.20 billion. Earnings were 132.41 million, an increase of 16.37%.

Financial Statements

News

EQS-PVR: Dermapharm Holding SE: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG

EQS Voting Rights Announcement: Dermapharm Holding SE Dermapharm Holding SE: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG 07.04.2026 / 10:08 C...

12 days ago - Wallstreet:Online

EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements Dermapharm Holding SE: Preliminary announcement of the public...

4 weeks ago - Wallstreet:Online